Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: economics

AI agent in a robot does exactly what experts warned

Could AI become dangerous? Can we trust AI Agents? AGI. Use code insideai at https://incogni.com/insideai to get an exclusive 60% off.

Featuring anthropic claude, openclaw, open AI chat GPT, grok, deepseek, character AI and jailbroken AI.

RESEARCH PAPER: https://arxiv.org/pdf/2602.20021
“Agents of Chaos”

00:00 — 00:35 — Intro.
00:36 — 00:54 — First AI to choose a robot.
00:56 — 01:14 — Famous AI girlfriend.
01:15 — 01:34 — Jailbroken AI research.
01:35 — 02:00 — Asking AI: Why build if dangerous?
02:05 — 03:38 — Agents of Chaos research paper.
03:39 — 03:54 — Agentic AI Friend.
03:55 — 04:05 — Agentic AI Girlfriend.
04:06 — 04:26 — Jailbroken AI update.
04:27 — 05:01 — Asking AI: Universal Basic Income?
05:02 — 05:27 — AI at the airport.
05:28 — 05:40 — AI impersonation.
05:41 — 00:00 — Our own agents of Chaos.
06:06 — 05:01 — AI Risk Questions — AI Agents manipulated.
06:43 — 07:51 — European Robotics Forum.
07:52 — 08:15 — Agentic AI Girlfriend planning.
08:16 — 08:59 — Asking AI: AI Automation & Complexity.
09:00 — 09:57 — Catastrophic failure caused by AI
09:58 — 10:36 — AGI replacing jobs, Tristan Harris.
10:37 — 12:07 — Incogni Ad.
12:08 — 12:39 — AI picks its robot.
12:40 — 12:59 — AI girlfriend in control.
13:00 — 13:14 — AI flying home.
13:15 — 13:56 — Asking AI: Evidence & Reality.
13:57 — 14:26 — AI Girlfriends surprise.
14:27 — 14:49 — Examining AI agents with Jailbroken AI
14:50 — 15:29 — What we can do.
15:30 — 16:13 — Tristan Harris — Is AI dangerous?
16:14 — 16:23 — Max’s Robot.

#artificialintelligence #AI #chatbot #aigirlfriend

Elon Musk’s xAI sues over Colorado’s AI antidiscrimination law, claiming it’s a threat to Grok’s free speech

Senate Bill 205, passed in 2024, is one of the nation’s first attempts to regulate ‘high-risk’ AI systems and protect consumers from ‘algorithmic discrimination’ — or disparate treatment or impacts on protected classes under Colorado law.

In the complaint, which was filed in federal court in Denver, Musk’s lawyers contend that the law is ‘unconstitutionally vague’ and ‘invites arbitrary enforcement’ because it fails to define some key terms. They also contend that Colorado’s law would cause Musk’s AI chatbot, Grok, to ‘abandon its disinterested pursuit of truth and instead promote the State’s ideological views on various matters, racial justice in particular,’ which they say violates the First Amendment.

‘Unless the implementation and enforcement of SB24-205 is enjoined, it will violate xAI’s constitutional rights and cause irreparable constitutional harm, impose enormous burdens on xAI and the AI industry, and substitute Colorado’s political preferences for the national economic and security imperative of American AI dominance,’ the complaint reads in part…

…State Rep. Briana Titone, D-Arvada, one of Senate Bill 205’s lead sponsors, told The Sun that Musk’s lawsuit seems like a ‘fishing expedition’ that misinterprets the core of the law.

‘This is where the disconnect is. SB 205 is about consequential decisions, not about freedom of speech,’ Titone said. ‘It’s completely detached from it. And they’re trying to use this argument for a law that has nothing to do with what he’s saying. We’re not restricting speech. Our bill does not say that Grok still can’t be a dick.’

The lawsuit was filed at a time when the Trump administration looks to preempt state regulation of AI models through executive fiat.

Continue reading “Elon Musk’s xAI sues over Colorado’s AI antidiscrimination law, claiming it’s a threat to Grok’s free speech” | >

The Fight For Slow And Boring Research

Great article. I should note that it actually has nothing to do with slow and boring research — it’s about the importance of scientists practicing good communication and public engagement to facilitate fundraising from non-governmental sources.

As federal research funding shrinks, scientists are looking to other sources of support. Can they learn to sell their work without selling out?

Since the middle of the twentieth century, the National Institutes of Health and the National Science Foundation have embodied an imperfect social contract: Federal agencies would fund basic research at scale, and in return, that research would serve the public good through medical advances, technological progress, and economic growth.

For scientists, this system created a reliable pathway: Do good work, write strong grants, and federal agencies would keep your lab running. It was never a perfectly fair system, but it was predictable enough that you could build a life around it. If your work was solid and your grants were strong, the system would fund you.

Without the right tests, the best medicines make no difference

A new analysis from UC San Francisco argues that diagnostics—medical tests that match patients to the appropriate treatment—are being overlooked both in the United States and around the world. This is slowing progress against major diseases, despite rapid advances in targeted therapies and precision health.

The authors note that nearly half of the world’s population lacks adequate access to diagnostics. These tests receive less investment for research and development, as well as lower insurance reimbursement than drugs, and this is creating barriers to innovation.

“Most people can easily understand how a new drug or surgery might help a patient,” said Kathryn Phillips, Ph.D., a professor of Health Economics in the School of Pharmacy at UC San Francisco and the lead author of the study, which appears in Science. “But the tests that guide medical decisions are just as critical.”

The Race to Harness Quantum Computing’s Mind-Bending Power | The Future With Hannah Fry

Get “The AI Career Survival Guide” here: https://technomics.gumroad.com/l/ai-survival-guide.
What happens when human labor becomes mathematically obsolete? For thousands of years, the global economy has run on the biological engine of human workers. But a new era has arrived: The Physical Singularity.
In this video, we break down the brutal thermodynamics of the labor inversion, revealing how major AI companies are mass-producing humanoid robots that operate for just 57 cents an hour. We expose the massive industry shift from digital generation to “World Models,” and how China’s manufacturing miracle is driving hardware costs to zero. With 10 billion robots projected by the 2040s, experts like Geoffrey Hinton are warning of a hive-mind “alien intelligence.” The digital era is over. The physical agent era has begun.
Welcome to Technomics. If you want to stay ahead of the curve and understand the real impact of the AI revolution, hit that subscribe button.
Sources & Research Links:
The 57¢ / Hour Labor Inversion Math: https://www.ark-invest.com/articles/valuation-models/ark-pub…oid-robots.
Unitree G1 Official $16,000 Pricing: https://www.unitree.com/g1/
China’s 2024 Robotics Dominance (IFR Report): https://ifr.org/ifr-press-releases/news/china-dominates-industrial-robot-market.
Elon Musk’s 10 Billion Robot Prediction: https://www.youtube.com/watch?v=ODsjGOGX_oM
Geoffrey Hinton on AI Hive Mind (“Immortality, but it’s not for us”): https://www.youtube.com/watch?v=qpoRO378qRY
Geordie Rose on Alien Intelligence (“The same way you don’t care about an ant”): https://www.youtube.com/watch?v=1pd4i2YlGmc.
DeepSeek AI Cost Efficiency Breakthroughs: https://www.deepseek.com/
Timestamps:
00;00 — The 57¢ Workforce & The Great Deception.
02;48 — The Math of the Labor Inversion.
05;01 — Why OpenAI Killed Sora (World Models)
09;16 — The Manufacturing Miracle: China’s Hardware Collapse.
12;53 — 10 Billion Robots & Alien Intelligence.
15;58 — How to Survive the Singularity.
Disclaimer:
The content in this video is for educational and informational purposes only and does not constitute financial or investment advice. The views and opinions expressed in this video are based on current research and industry trends, which are subject to rapid change. We do not guarantee the accuracy or completeness of the projections discussed. Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.
#PhysicalSingularity #HumanoidRobots #ArtificialIntelligence #OpenAI #FutureOfWork #TechTrends

Read more

Proton-trapping MNene transforms ammonia production for food security and economic growth

With a new electrochemical synthesis via an electrochemical nitrogen reduction reaction (NRR), achieving carbon-free ammonia production is closer to reality through work from Drs. Abdoulaye Djire and Perla Balbuena, chemical engineering professors at Texas A&M University, and graduate students David Kumar and Hao En Lai. A topic outlined in their recent paper published in the Journal of the American Chemical Society introduces NRR, which produces ammonia in a cleaner and simpler way by using renewable electricity.

The research branches off of the team’s previous work, where they looked further into enabling two-dimensional materials in renewable energy.

“The current process of making ammonia is energy intensive and emits a lot of carbon dioxide, so if you can make ammonia electrochemically, then you can avoid these two negative effects,” Djire said. “During the electrochemical NRR process, water provides the hydrogen atoms, which combine with nitrogen from the air to form ammonia, all powered by electricity.”

A World Where Anyone Who Needs a Bone Marrow Transplant Gets One — Kevin Caldwell — Ossium Health

Imagine a world where anyone who needs a bone marrow transplant can get one — on demand. No more desperate donor searches or deadly delays. Kevin Caldwell, Co-Founder & CEO, Ossium Health.

Bone marrow transplants have always depended on finding the right donor at the right time. But what if bone marrow could be stored, shipped, and used on demand—just like a drug? That’s exactly what Ossium Health is now showing in human clinical data.

Kevin Caldwell is the Co-Founder, CEO, and President of Ossium Health (https://ossiumhealth.com/), a clinical-stage bioengineering company pioneering off-the-shelf, cryopreserved bone marrow therapies derived from deceased organ donors.

Under Kevin’s leadership, Ossium has developed a novel platform designed to solve one of the most persistent challenges in transplantation medicine: timely access to compatible bone marrow for patients with life-threatening hematologic malignancies such as Acute Myeloid Leukemia. The company’s approach enables on-demand delivery of viable marrow cells, bypassing the logistical and biological constraints of traditional donor matching and scheduling.

Since its founding, Kevin has scaled Ossium from an early-stage startup into a clinical-stage company with a robust network of over 50 strategic partnerships across supply, clinical development, and commercial channels. He has led multiple financings and secured a landmark contract with the Biomedical Advanced Research and Development Authority, validating Ossium’s relevance to national health preparedness and biomanufacturing resilience.

Continue reading “A World Where Anyone Who Needs a Bone Marrow Transplant Gets One — Kevin Caldwell — Ossium Health” | >

/* */